热门资讯> 正文
Annovis启动600万美元注册直接发行
2025-10-10 20:58
- Annovis Bio (NYSE:ANVS) has entered into definitive agreements for the purchase of an aggregate of 4M shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.50 per share in a registered direct offering, fr gross proceeds of ~$6 million.
- The closing of the offering is expected to occur on or about October 13, 2025.
- ANVS -27.27% premarket to $1.6.
- Source: Press Release
More on Annovis Bio
- Seeking Alpha’s Quant Rating on Annovis Bio
- Financial information for Annovis Bio
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。